Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Emerging Drugs and Targets for Multiple Sclerosis -

Emerging Drugs and Targets for Multiple Sclerosis

Ana Martinez (Herausgeber)

Buch | Hardcover
352 Seiten
2019
Royal Society of Chemistry (Verlag)
978-1-78801-450-2 (ISBN)
CHF 277,55 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This series provides a comprehensive resource for postgraduate students and for scientists in academia or industry wanting to learn topics outside their own areas of expertise.
The Drug Discovery Series covers all aspects of drug discovery and medicinal chemistry and contains over 70 books published since 2010. Providing comprehensive coverage of this important and far-reaching area, the books encourage learning in a range of different topics and provide valuable reference sources for scientists working outside their areas of expertise. Books feature case studies to bring different aspects of the drug discovery process alive and they detail the fundamental science necessary for understanding through to the most up-to-date discoveries and cutting edge technologies. Chapters are written and edited by experienced researchers from both industry and academia. This series will be of particular interest to postgraduate students and medicinal chemists and biochemists working in academia or industry.

Multiple Sclerosis: Epidemiology, Genetics, Symptoms, and Unmet Needs; Genetics of Multiple Sclerosis; Biomarkers for Multiple Sclerosis; Optical Coherence Tomography in Multiple Sclerosis; Experimental in vivo Models for Drug Discovery in Multiple Sclerosis; Progressive Multiple Sclerosis: Drug Discovery; B Cells-based Therapies for Multiple Sclerosis; Protein Kinase Inhibitors for the Treatment of Multiple Sclerosis; Emerging Drugs and Targets for Remyelination in Multiple Sclerosis; Regulation of Oligodendrocyte Differentiation: New Targets for Drug Discovery in Remyelination; Cannabinoids as a Therapeutic Approach in Multiple Sclerosis; Sigma Receptors as New Target for Multiple Sclerosis; Non-Coding RNA and Multiple Sclerosis: New targets for Drug Discovery; Diet, Gut Microbiome and Multiple Sclerosis

Erscheinungsdatum
Reihe/Serie Drug Discovery ; Volume 70
Verlagsort Cambridge
Sprache englisch
Maße 156 x 234 mm
Gewicht 611 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Chemie Organische Chemie
ISBN-10 1-78801-450-2 / 1788014502
ISBN-13 978-1-78801-450-2 / 9781788014502
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75